Détails du produit
Synonyms
DDPAC, FTDP-17, MAPT, MSTD, MTBT1, Tau, PHF-tau, TAU
Source
Human Tau-381 / 1N3R Protein, Tag Free (TAU-H5112) is expressed from E. coli cells. It contains AA Met 1 - Leu 381 (Accession # P10636-4).
Predicted N-terminus: Met 1
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries no "tag".
The protein has a calculated MW of 39.7 kDa. The protein migrates as 43-55 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
Endotoxin
Less than 0.01 EU per μg by the LAL method / rFC method.
Purity
>90% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
Formulation
Supplied as 0.2 μm filtered solution in 20 mM Tris, 150 mM NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
Shipping
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 3 months under sterile conditions.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
SDS-PAGE

Human Tau-381 / 1N3R Protein, Tag Free on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS

The purity of Human Tau-381 / 1N3R Protein, Tag Free (Cat. No. TAU-H5112) is more than 95% and the molecular weight of this protein is around 30-50 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA

Immobilized Human Tau-381 / 1N3R Protein, Tag Free (Cat. No. TAU-H5112) at 1 μg/mL (100 μL/well) can bind Tau Monoclonal Antibody with a linear range of 0.1-2 ng/mL (QC tested).
Protocol
Avis des utilisateurs Publier un commentaire

Introduction de fond
Progrès de frontière
- Nom anglais:
Microtubule-associated protein tau
- Catégorie:
- Nombre de médicaments répertoriés:
1 Détails
- Nombre de médicaments cliniques:
46 Détails
- Étape de développement la plus élevée:
Approved



















